
Sign up to save your podcasts
Or


Hot off the press in the Presidential Plenary at #ESMO25, we chat with Dr Scott Tagawa (Weill-Cornell, USA) about the positive data he just presented from the PSMAddition trial. This is an eagerly awaited phase III randmosied trial of patients with mHSPC, to see if the addition of six cycles of Lu-PSMA-617 to a control arm of ADT and an ARPI, could improve rPFS and other endpoints. We are also joined in the studio by Prof Michael Hofman (Peter MacCallum Cancer Centre, AUS), co-PI of the UpFront PSMA trial which also explored a similar concept, plus some comments from our other colleague, prof Arun Azad, who was the Discussant in the Presidential at ESMO25.
Declan Murphy hosting GU Cast solo today while Renu Eapen was in the OR doing surgery.
Even better on our YouTube channel
This is a Themed Podcast supported by our Silver Partners, Novartis.
By Professor Declan Murphy & Dr Renu Eapen4.5
22 ratings
Hot off the press in the Presidential Plenary at #ESMO25, we chat with Dr Scott Tagawa (Weill-Cornell, USA) about the positive data he just presented from the PSMAddition trial. This is an eagerly awaited phase III randmosied trial of patients with mHSPC, to see if the addition of six cycles of Lu-PSMA-617 to a control arm of ADT and an ARPI, could improve rPFS and other endpoints. We are also joined in the studio by Prof Michael Hofman (Peter MacCallum Cancer Centre, AUS), co-PI of the UpFront PSMA trial which also explored a similar concept, plus some comments from our other colleague, prof Arun Azad, who was the Discussant in the Presidential at ESMO25.
Declan Murphy hosting GU Cast solo today while Renu Eapen was in the OR doing surgery.
Even better on our YouTube channel
This is a Themed Podcast supported by our Silver Partners, Novartis.

893 Listeners

299 Listeners

884 Listeners

37 Listeners

830 Listeners

301 Listeners

8,512 Listeners

1,806 Listeners

57 Listeners

15,636 Listeners

53 Listeners

3 Listeners

2,906 Listeners

2,480 Listeners

2,156 Listeners